Considering the small effect of metformin on the proliferation of CD133– cells and the key role of cancer stem cells in tumor progression, invasion, and metastasis [28], [29], we tentatively suggest that selective inhibition of CD133+ cells contributes significantly to the in vitro and in vivo anticancer effect of metformin. Here, PROM1 is linked to cancer.